Eli Lilly and Company (LLY) has a MoatMap StockRank of 62/100 based on Quality (67/100), Value (12/100), and Momentum (66/100) factor scores. The current signal is HOLD. Eli Lilly, a top-tier pharmaceutical company with a strong pipeline and undeniable quality, is already largely priced for its significant growth prospects, lacking an unpriced asymmetric macro tailwind from the specified themes for this fund's criteria.